Literature DB >> 27114526

Relevance of the COPI complex for Alzheimer's disease progression in vivo.

Karima Bettayeb1, Basaraj V Hooli2, Antonio R Parrado2, Lisa Randolph1, Dante Varotsis1, Suvekshya Aryal1, Jodi Gresack1, Rudolph E Tanzi2, Paul Greengard3, Marc Flajolet3.   

Abstract

Cellular trafficking and recycling machineries belonging to late secretory compartments have been associated with increased Alzheimer's disease (AD) risk. We have shown that coat protein complex I (COPI)-dependent trafficking, an early step in Golgi-to-endoplasmic reticulum retrograde transport, affects amyloid precursor protein subcellular localization, cell-surface expression, as well as its metabolism. We present here a set of experiments demonstrating that, by targeting subunit δ-COP function, the moderation of the COPI-dependent trafficking in vivo leads to a significant decrease in amyloid plaques in the cortex and hippocampus of neurological 17 mice crossed with the 2xTg AD mouse model. Remarkably, an improvement of the memory impairments was also observed. Importantly, human genetic association studies of different AD cohorts led to the identification of 12 SNPs and 24 mutations located in COPI genes linked to an increased AD risk. These findings further demonstrate in vivo the importance of early trafficking steps in AD pathogenesis and open new clinical perspectives.

Entities:  

Keywords:  Alzheimer; COPI; EWAS studies; GWAS studies; human genetic

Mesh:

Substances:

Year:  2016        PMID: 27114526      PMCID: PMC4868486          DOI: 10.1073/pnas.1604176113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.

Authors:  Fusheng Chen; Hiroshi Hasegawa; Gerold Schmitt-Ulms; Toshitaka Kawarai; Christopher Bohm; Taiichi Katayama; Yongjun Gu; Nobuo Sanjo; Michael Glista; Ekaterina Rogaeva; Yosuke Wakutani; Raphaëlle Pardossi-Piquard; Xueying Ruan; Anurag Tandon; Frédéric Checler; Philippe Marambaud; Kirk Hansen; David Westaway; Peter St George-Hyslop; Paul Fraser
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

2.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

3.  A new multipoint method for genome-wide association studies by imputation of genotypes.

Authors:  Jonathan Marchini; Bryan Howie; Simon Myers; Gil McVean; Peter Donnelly
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

4.  Presenilin-1-mediated retention of APP derivatives in early biosynthetic compartments.

Authors:  Marloes Réchards; Weiming Xia; Viola Oorschot; Suzanne van Dijk; Willem Annaert; Dennis J Selkoe; Judith Klumperman
Journal:  Traffic       Date:  2006-03       Impact factor: 6.215

5.  Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester.

Authors:  M J Savage; S P Trusko; D S Howland; L R Pinsker; S Mistretta; A G Reaume; B D Greenberg; R Siman; R W Scott
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

6.  COPI-mediated retrograde transport is required for efficient gamma-secretase cleavage of the amyloid precursor protein.

Authors:  Alexandra Selivanova; Bengt Winblad; Mark R Farmery; Nico P Dantuma; Maria Ankarcrona
Journal:  Biochem Biophys Res Commun       Date:  2006-09-18       Impact factor: 3.575

7.  A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Authors:  C Janus; J Pearson; J McLaurin; P M Mathews; Y Jiang; S D Schmidt; M A Chishti; P Horne; D Heslin; J French; H T Mount; R A Nixon; M Mercken; C Bergeron; P E Fraser; P St George-Hyslop; D Westaway
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

8.  Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease.

Authors:  Richard E Hartman; Yukitoshi Izumi; Kelly R Bales; Steven M Paul; David F Wozniak; David M Holtzman
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

9.  GEMINI: integrative exploration of genetic variation and genome annotations.

Authors:  Umadevi Paila; Brad A Chapman; Rory Kirchner; Aaron R Quinlan
Journal:  PLoS Comput Biol       Date:  2013-07-18       Impact factor: 4.475

10.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

Authors:  Hao Li; Sally Wetten; Li Li; Pamela L St Jean; Ruchi Upmanyu; Linda Surh; David Hosford; Michael R Barnes; James David Briley; Michael Borrie; Natalie Coletta; Richard Delisle; Daniella Dhalla; Margaret G Ehm; Howard H Feldman; Luis Fornazzari; Serge Gauthier; Neil Goodgame; Danilo Guzman; Sandra Hammond; Paul Hollingworth; Ging-Yuek Hsiung; Joan Johnson; Devon D Kelly; Ron Keren; Andrew Kertesz; Karen S King; Simon Lovestone; Inge Loy-English; Paul M Matthews; Michael J Owen; Mary Plumpton; William Pryse-Phillips; Rab K Prinjha; Jill C Richardson; Ann Saunders; Andrew J Slater; Peter H St George-Hyslop; Sandra W Stinnett; Jina E Swartz; Rachel L Taylor; John Wherrett; Julie Williams; David P Yarnall; Rachel A Gibson; Michael C Irizarry; Lefkos T Middleton; Allen D Roses
Journal:  Arch Neurol       Date:  2007-11-12
View more
  10 in total

1.  Copb2 is essential for embryogenesis and hypomorphic mutations cause human microcephaly.

Authors:  Andrew DiStasio; Ashley Driver; Kristen Sund; Milene Donlin; Ranjith M Muraleedharan; Shabnam Pooya; Beth Kline-Fath; Kenneth M Kaufman; Cynthia A Prows; Elizabeth Schorry; Biplab Dasgupta; Rolf W Stottmann
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

2.  Altered gene expression and PTSD symptom dimensions in World Trade Center responders.

Authors:  Laura M Huckins; Adriana Feder; Shelby Marchese; Leo Cancelmo; Olivia Diab; Leah Cahn; Cindy Aaronson; Nikolaos P Daskalakis; Jamie Schaffer; Sarah R Horn; Jessica S Johnson; Clyde Schechter; Frank Desarnaud; Linda M Bierer; Iouri Makotkine; Janine D Flory; Michael Crane; Jacqueline M Moline; Iris G Udasin; Denise J Harrison; Panos Roussos; Dennis S Charney; Karestan C Koenen; Steven M Southwick; Rachel Yehuda; Robert H Pietrzak
Journal:  Mol Psychiatry       Date:  2022-02-17       Impact factor: 13.437

3.  Mutations in the COPI coatomer subunit α-COP induce release of Aβ-42 and amyloid precursor protein intracellular domain and increase tau oligomerization and release.

Authors:  Jacob W Astroski; Leonora K Akporyoe; Elliot J Androphy; Sara K Custer
Journal:  Neurobiol Aging       Date:  2021-01-13       Impact factor: 4.673

4.  A paralog-specific role of COPI vesicles in the neuronal differentiation of mouse pluripotent cells.

Authors:  Manu Jain Goyal; Xiyan Zhao; Mariya Bozhinova; Karla Andrade-López; Cecilia de Heus; Sandra Schulze-Dramac; Michaela Müller-McNicoll; Judith Klumperman; Julien Béthune
Journal:  Life Sci Alliance       Date:  2020-07-14

5.  Genetic and Expression Analysis of COPI Genes and Alzheimer's Disease Susceptibility.

Authors:  Yu Yang; Xu Wang; Weina Ju; Li Sun; Haining Zhang
Journal:  Front Genet       Date:  2019-09-19       Impact factor: 4.599

6.  Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons.

Authors:  Christopher Sackmann; Martin Hallbeck
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

7.  Biallelic variants in COPB1 cause a novel, severe intellectual disability syndrome with cataracts and variable microcephaly.

Authors:  William L Macken; Annie Godwin; Gabrielle Wheway; Karen Stals; Liliya Nazlamova; Sian Ellard; Ahmed Alfares; Taghrid Aloraini; Lamia AlSubaie; Majid Alfadhel; Sulaiman Alajaji; Htoo A Wai; Jay Self; Andrew G L Douglas; Alexander P Kao; Matthew Guille; Diana Baralle
Journal:  Genome Med       Date:  2021-02-25       Impact factor: 11.117

8.  Paracrine Interleukin 6 Induces Cerebral Remodeling at Early Stages After Unilateral Common Carotid Artery Occlusion in Mice.

Authors:  Melanie T C Kuffner; Stefan P Koch; Marieluise Kirchner; Susanne Mueller; Janet Lips; Jeehye An; Philipp Mertins; Ulrich Dirnagl; Matthias Endres; Philipp Boehm-Sturm; Christoph Harms; Christian J Hoffmann
Journal:  Front Cardiovasc Med       Date:  2022-01-27

9.  Temporal Quantitative Profiling of Newly Synthesized Proteins during Aβ Accumulation.

Authors:  Yuanhui Ma; Daniel B McClatchy; Salvador Martínez-Bartolomé; Casimir Bamberger; John R Yates
Journal:  J Proteome Res       Date:  2020-11-04       Impact factor: 4.466

10.  GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer's disease.

Authors:  Peng Xu; Jerry C Chang; Xiaopu Zhou; Wei Wang; Michael Bamkole; Eitan Wong; Karima Bettayeb; Lu-Lin Jiang; Timothy Huang; Wenjie Luo; Huaxi Xu; Angus C Nairn; Marc Flajolet; Nancy Y Ip; Yue-Ming Li; Paul Greengard
Journal:  J Exp Med       Date:  2021-06-22       Impact factor: 17.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.